IMR Press / RCM / Volume 11 / Issue S2 / 10.3909/ricm11S2S0004

Reviews in Cardiovascular Medicine (RCM) is published by IMR Press from Volume 19 Issue 1 (2018). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by IMR Press on as a courtesy and upon agreement with MedReviews, LLC.

Open Access Review
Natriuretic Peptides in the Prognosis and Management of Acute Coronary Syndromes
Show Less
1 Donald W. Reynolds Cardiovascular Research Center and Division of Cardiology, University of Texas Southwestern Medical Center, Dallas TX
2 Cleveland Clinic Foundation, Cleveland, OH
3 Department of Medicine, Divisions of Cardiology, Nutrition, and Preventive Medicine, William Beaumont Hospital, Royal Oak, MI
Rev. Cardiovasc. Med. 2010, 11(S2), 24–34;
Published: 20 February 2010
Over the past decade, an evidence base has accumulated to support natriuretic peptide (NP) testing for diagnosis, risk assessment, and therapeutic monitoring and guidance of patients with heart failure. Investigators have also explored multiple other potential uses for these tests, including risk assessment of patients with suspected acute coronary syndromes (ACS). This article discusses the utility of NPs in the diagnosis and management of patients with ACS.
Acute coronary syndromes
Natriuretic peptides
Risk assessment
Management strategies
Back to top